Matthew Rausch

Family Medicine

190 Stetson Rd
Auburn, ME 04210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7 publications

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies.

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies.

Journal: Journal of hematology & oncology

Published: July 28, 2025

Endogenous IL-27 during toxoplasmosis limits early monocyte responses and their inflammatory activation by pathological T cells.

Endogenous IL-27 during toxoplasmosis limits early monocyte responses and their inflammatory activation by pathological T cells.

Journal: mBio

Published: February 20, 2024

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

Journal: ImmunoHorizons

Published: November 16, 2022

IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.

IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.

Journal: Cancer discovery

Published: November 07, 2020

Corrigendum: PI3Kγ is a molecular switch that controls immune suppression.

Corrigendum: PI3Kγ is a molecular switch that controls immune suppression.

Journal: Nature

Published: December 16, 2016

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.

Journal: Nature

Published: September 29, 2016

PI3Kγ is a molecular switch that controls immune suppression.

PI3Kγ is a molecular switch that controls immune suppression.

Journal: Nature

Published: March 14, 2016

Showing 1-7 of 7

Last Updated: 09/26/2026